Newport issues 3Q warning

September 24, 2003 – Newport Corp., Irvine, CA, says its 3Q sales will come in at $31 million to $33 million, roughly 15% below previous estimates. The company now predicts a 3Q net loss of $0.05 to $0.08 per share, instead of an anticipated guidance of ($0.02) to $0.02 per share.

“A number of the shipments we anticipated for the quarter will shift into the fourth quarter of this year and beyond,” said chairman and CEI Robert Deuster.

Contributing to the decline are product delays at the company’s largest OEM in the life and health sciences market, as well as delays in orders from back-end semiconductor companies and lower-then-expected orders from front-end customers.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.